Survival: | ? |
Toxicity Grade: | 4 |
Treatments: | Chemotherapy |
Drugs: | Doxil |
Country: | United States |
City/State/Province: | Minneapolis, Minnesota |
Hospital: | University of Minnesota Medical School |
Journal: | Link |
Date: | 1/2002 |
Description: |
Patients: This Phase II study involved 15 patients with mesothelioma. Treatment: The treatment consisted of the administration of the drug, doxorubicin (doxil). Toxicity: Toxicities included neutrophils (grade 3 and 4), skin (grade 1 and 2), mucositis (grade 1 and 2), nausea (grade 1), and fatigue (grade 1). Results: One patient had a partial response. Overall survival was not discussed. |